EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Real-Life Prognosis of Sinonasal Tumors

Giancarlo Pecorari iD, Gian Marco Motatto, Federica Piazza, Alessandro Garzaro, Giuseppe Riva iD

Journal of Personalized Medicine · 24.04.2024 · 14 (5) · 444

DOI: 10.3390/jpm14050444 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Personalized Medicine, online erschienen am 24.04.2024. Verfasst von Giancarlo Pecorari und 4 weiteren Autor:innen. Beteiligte Einrichtung: Division of Otorhinolaryngology, Department of Surgical Sciences, University of Turin, 10126 Turin, Italy. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Sinonasal cancer represents a challenging disease because of its difficult diagnosis and different histology. Despite a multidisciplinary evaluation and treatments, a poor prognosis is still present. We retrospectively analyzed patients with sinonasal cancer treated in our institution, paying attention to histology and real-life prognosis.

Methods

A total of 51 consecutive patients were included in the study. Clinical features were described. Overall, disease-free, and disease-specific survival (OS, DFS, DSS) according to histology were calculated. Kaplan–Meyer estimator curves were reported.

Results

The most prevalent primary tumor was squamous cell carcinoma, followed by adenocarcinoma. Global 2- and 5-year OS was 68.80% and 54.58%, respectively. Global 2- and 5-year DFS was 48.53% and 29.56%, while global 2- and 5-year DSS was 82.86% and 74.57%, respectively. The median OS was 74 and 43 months for early- and late-stage cancer, respectively. The Cox multivariate regression analysis did not reveal any statistically significant effects of age, stage, or histology on survival outcomes.

Conclusions

The diagnosis is often late and the prognosis poor. An appropriate treatment, which is always quite multimodal, allows us to achieve a global 5-year OS slightly higher than 50%. An adequate diagnosis to increase the percentage of early-stage tumors is mandatory to improve prognosis.

Schlagwörter

Stichwörter der Autor:innen

nasal tumorsreal-life prognosissinonasal cancersurvival

Autor:innen und Institutionen

  • Division of Otorhinolaryngology, Department of Surgical Sciences, University of Turin, 10126 Turin, Italy.

ORCID-Profile: Giancarlo Pecorari, Giuseppe Riva

Zitieren

APA

Pecorari, G., Motatto, G. M., Piazza, F., Garzaro, A., & Riva, G. (2024). Real-Life Prognosis of Sinonasal Tumors. Journal of Personalized Medicine, 14(5), 444. https://doi.org/10.3390/jpm14050444

Vancouver

Pecorari G, Motatto GM, Piazza F, Garzaro A, Riva G. Real-Life Prognosis of Sinonasal Tumors. Journal of Personalized Medicine. 2024;14(5):444. doi:10.3390/jpm14050444

BibTeX
@article{Pecorari2024,
  author = {Pecorari, Giancarlo and Motatto, Gian Marco and Piazza, Federica and Garzaro, Alessandro and Riva, Giuseppe},
  title = {Real-Life Prognosis of Sinonasal Tumors},
  journal = {Journal of Personalized Medicine},
  year = {2024},
  volume = {14},
  number = {5},
  pages = {444},
  doi = {10.3390/jpm14050444}
}
Kostenlos starten →